Solving the Gross-to-Net Bubble With Better Data – RetailWit

Solving the Gross-to-Net Bubble With Better Data – RetailWit

Today’s guest post comes from Angie Franks, CEO at Kalderos. Angie examines how data fragmentation contributes to inefficiencies in drug discount programs and the broader gross-to-net bubble—the widening difference between a drug’s revenue at list prices and what manufacturers actually receive. Angie outlines how better access to consistent, claims-level data could help reduce waste, improve program integrity, and enhance collaboration among sta…

Gross-to-Net Bubble Reshapes Drug Pricing Strategy

As over half of Americans now receive prescriptions through Medicare or Medicaid, pharma companies must shift from a commercial-first approach to a statutory-first model, making GTN governance a C-suite priority for long-term brand survival.

Fragmented Data Linked to Inefficiencies in Drug Discount Programs and Widening Gross-to-Net Gap

A recent analysis highlights the role of fragmented dat […] The post Fragmented Data Linked to Inefficiencies in Drug Discount Programs and Widening Gross-to-Net Gap first appeared on GeneOnline News. The post Fragmented Data Linked to Inefficiencies in Drug Discount Programs and Widening Gross-to-Net Gap appeared first on GeneOnline News.